Sign Up to like & get
recommendations!
1
Published in 2019 at "Journal of the National Comprehensive Cancer Network : JNCCN"
DOI: 10.6004/jnccn.2019.5016
Abstract: Biosimilars are here to stay, but whether they will enjoy widespread uptake remains to be seen. The FDA sets a high bar for approval of biosimilar products, yet many clinicians remain skeptical about the efficacy…
read more here.
Keywords:
factors anemia;
biosimilar approvals;
myeloid growth;
growth factors ... See more keywords